Balyasny Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
1CP
Balyasny Asset Management's BME Position: Q3 2025 in Review
Balyasny Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q3 2025, closing a stake of 10,594 shares — an estimated $386K sold.
Balyasny Asset Management first reported a position in BME in Q2 2025 and held it in 1 quarter. The position peaked at $386K in Q2 2025. 76 funds tracked by Wall St. Rank hold BME as of Q3 2025.
- Balyasny Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q3 2025 after selling out during the quarter.
- Balyasny Asset Management sold 10,594 BlackRock Health Sciences Trust shares in Q3 2025, an estimated $386K.
- Balyasny Asset Management first reported a position in BlackRock Health Sciences Trust in Q2 2025 and held it in 1 quarter.
- Balyasny Asset Management's BlackRock Health Sciences Trust position peaked at $386K in Q2 2025.
- 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2025.
Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.